CN103599329A - Externally-used traditional Chinese medicinal pulvis for treating allergic skin diseases - Google Patents

Externally-used traditional Chinese medicinal pulvis for treating allergic skin diseases Download PDF

Info

Publication number
CN103599329A
CN103599329A CN201310513622.XA CN201310513622A CN103599329A CN 103599329 A CN103599329 A CN 103599329A CN 201310513622 A CN201310513622 A CN 201310513622A CN 103599329 A CN103599329 A CN 103599329A
Authority
CN
China
Prior art keywords
parts
radix
herba
traditional chinese
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310513622.XA
Other languages
Chinese (zh)
Inventor
易茹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Vocational and Technical College of Industry and Trade
Original Assignee
Anhui Vocational and Technical College of Industry and Trade
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Vocational and Technical College of Industry and Trade filed Critical Anhui Vocational and Technical College of Industry and Trade
Priority to CN201310513622.XA priority Critical patent/CN103599329A/en
Publication of CN103599329A publication Critical patent/CN103599329A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses an externally-used traditional Chinese medicinal pulvis for treating allergic skin diseases. The traditional Chinese medicinal pulvis is prepared by drying raw materials, crushing, and sieving by a 100 mesh sieve, and the raw materials comprises, by weight, 10-30 parts of Herba Schizonepetae, 20-30 parts of Divaricate Saposhnikovia Root, 15-25 parts of Fructus Cnidii, 12-18 parts of Sophora flavescens, 30-50 parts of Siberian cocklebur worm, 20-40 parts of unprepared rehmannia root, 10-20 parts of Chinese angelica, 5-15 parts of Radix Paeoniae Rubra, 5-15 parts of white peony root, 10-20 parts of Polygonum multiflorum Thunb, 5-15 parts of Herbal Ephedrae, 5-15 parts of Commom Duckweed, 3-7 parts of Glabrous Greenbrier Rhizome, 1-3 parts of periostracum cicadae and 0.3-1 part of centipede. Traditional Chinese medicines comprising the periostracum cicadae, the centipede and the Siberian cocklebur worm are used as components of the traditional Chinese medicinal composition, so the composition has the advantages of definite therapeutic effect, high cure rate and high effective rate; and the composition is a pulvis which can be externally used, and has no gastrointestinal tract side effects of orally-administrated medicines after long-term use.

Description

A kind of external application Chinese medicine powder for the treatment of allergic skin diseases
Technical field
The invention belongs to medical technical field, be specifically related to a kind of external application Chinese medicine powder for the treatment of allergic skin diseases.
Background technology
Measles clinical manifestation is the localized edema welt differing in size.Welt color can be cerise, pale red, pale asphyxia or skin-color, and form can rounded, oval, annular or irregular shape.Welt can occur suddenly in several minutes, can in several minutes to a few hours, disappear, and did not stay any vestige, but this plays that again, outbreak repeatedly.Its Clinical symptoms, for occurring rapidly and disappearing, is stepped back without vestige, with play, itches.Severe patient can be with headache, dizziness, arthralgia, stomachache, nausea,vomiting,diarrhea, uncomfortable in chest, nervous, hoarseness, dyspnea, can there is the anaphylactic shock such as laryngeal edema, pale complexion, heart rate accelerate, pulse is thin and delicate, blood pressure drops, confusion, threat to life in severe patient.Clinical in course of disease length, generally that onset is anxious, the course of disease was called acute urticaria at three months with interior person, and its morbidity is hurried, welt number is more, how with General Symptoms; More than welt repeatedly shows effect and surpasses three months, person is called chronic urticaria, few when many during its welt, but most welt is less, and General Symptoms is lighter.
The common cause of disease of urticaria has: 1. food: as fish, shrimp, Eriocheir sinensis, egg or milk etc.2. medicine: penicillin, furazolidone, serum, vaccine etc.3. infect: tonsillitis, viral hepatitis, Enterozoa etc.4. animal and plant factor: as sucked scurf, feather or the pollen etc. of animal.5. physics and chemical factor: as hot and cold, daylight, friction and pressure etc.6. internal organs and general disease and nervously all can bring out primary disease.
At present, treat clinically the conventional antihistamine drug of urticaria.First generation antihistaminic is as chlorphenamine, Cyproheptadine etc.; The second filial generation is as loratadine, cetirizine, mizolastine etc.Although antihistaminic is evident in efficacy, application is conveniently widely adopted, and because drug withdrawal is easily recurred and has certain toxic and side effects to limit clinical practice, especially child suffers from this after being ill, is unfavorable for long-term taking antihistamine drug.And Chinese medicine urticaria is emphasized organic conception, curative effect is sure, and side effect is little.
Summary of the invention
The external application Chinese medicine powder that the object of this invention is to provide a kind of easy to use, curative effect is reliable, side effect is little treatment allergic skin diseases.
For solving the problems of the technologies described above, the technical solution adopted in the present invention is as follows:
Treat an external application Chinese medicine powder for allergic skin diseases, described Chinese medicine powder is crossed 100 mesh sieves by the component drying and crushing of following weight portion and is prepared from:
Herba Schizonepetae 10~30, Radix Saposhnikoviae 20~30, Fructus Cnidii 15~25, Radix Sophorae Flavescentis 12~18, Herba Xanthii worm 30~50,20~40 parts, the Radix Rehmanniae, 10~20 parts of Radix Angelicae Sinensis, 5~15 parts of Radix Paeoniae Rubra, 5~15 parts of the Radix Paeoniae Albas, 10~20 parts of the Radixs Polygoni Multiflori, 5~15 parts, Herba Ephedrae, 5~15 parts, Herba Spirodelae, 3~7 parts of Rhizoma Smilacis Glabraes, 1~3 part of Periostracum Cicadae, 0.3~1 part of Scolopendra.
On the basis of technique scheme, described Chinese medicine powder is crossed 100 mesh sieves by the component drying and crushing of following weight portion and is prepared from:
Herba Schizonepetae 10~20, Radix Saposhnikoviae 20~30, Fructus Cnidii 15~25, Radix Sophorae Flavescentis 12~15, Herba Xanthii worm 30~40,20~30 parts, the Radix Rehmanniae, 10~20 parts of Radix Angelicae Sinensis, 5~10 parts of Radix Paeoniae Rubra, 5~10 parts of the Radix Paeoniae Albas, 10~15 parts of the Radixs Polygoni Multiflori, 5~10 parts, Herba Ephedrae, 5~15 parts, Herba Spirodelae, 3~7 parts of Rhizoma Smilacis Glabraes, 1~3 part of Periostracum Cicadae, 0.3~1 part of Scolopendra.
Further, above-mentioned Chinese medicine powder is crossed 100 mesh sieves by the component drying and crushing of following weight portion and is prepared from:
Herba Schizonepetae 20, Radix Saposhnikoviae 25, Fructus Cnidii 20, Radix Sophorae Flavescentis 15, Herba Xanthii worm 40,30 parts, the Radix Rehmanniae, 115 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of the Radix Paeoniae Albas, 15 parts of the Radixs Polygoni Multiflori, 10 parts, Herba Ephedrae, 10 parts, Herba Spirodelae, 5 parts of Rhizoma Smilacis Glabraes, 2 parts of Periostracum Cicadaes, 0.5 part of Scolopendra.
In Chinese medicine composition component of the present invention, using Periostracum Cicadae, Scolopendra, Herba Xanthii echiuran raw material is Chinese medicine, and wherein, Periostracum Cicadae has loose wind heat extraction, sore-throat relieving, rash, nebula removing effect, for diseases such as measles without adequate eruption, rubella pruritus, conjunctival congestion cataractas.Scolopendra is warm in nature, and acrid in the mouth is poisonous, has the function of endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain, can be used for the skin disorders such as rheumatoid arthritis stubborn, skin infection.
The sweet Han Zhirun of the Radix Rehmanniae using in component, clearing up internal heat by using drugs of bitter in taste and cold in nature, cool and can fall apart, profit and oiliness, GUIXIN, liver, lung meridian, join the army minute, blood system, is the key medicine of clearing away heat from YING and blood systems, YIN nourishing and the production of body fluid promoting.Radix Angelicae Sinensis nature and flavor are sweet, pungent, warm, return liver, the heart, spleen channel, and having enriches blood invigorates blood circulation, menstruction regulating and pain relieving, and the effect of loosening bowel to relieve constipation, can be used for blood deficiency and yellow complexion, dizzy cardiopalmus, amenorrhea stimulates the menstrual flow, rheumatic arthralgia, traumatic injury, ulcer sores etc.Radix Paeoniae Rubra bitter in the mouth, cool in nature, there is the effect of blood stasis dispelling, pain relieving, removing heat from blood, detumescence.
And the Radix Paeoniae Alba has the effects such as the yin fluid astringing of nourishing blood, suppressing liver-YANG, easing the affected liver to relieve pain, adjusting immunity, be generally used for deficiecny of liver-YIN, excessive rising of liver-YANG, the diseases such as stagnation of liver-QI with deficiency of the spleen, blood deficiency or YinXuXueRe.
The Radix Polygoni Multiflori has invigorating the liver and kidney, benefiting essence-blood, black beard and hair, bone and muscle strengthening, blood fat reducing, antidotal effect.Radix Saposhnikoviae acrid-sweet flavor, tepor, returns lung, bladder, Liver Channel, effect expelling pathogenic wind from the body surface, victory is wet, relieving convulsion.
Herba Spirodelae cures mainly the diseases such as pathogenic factor in the exterior heating, measles, edema.
Clinical efficacy of the present invention is definite, and cure rate and effective percentage are high; The present invention is pure Chinese medicinal preparation, puts on the skin easy to usely with powder outward, and life-time service is without the gastrointestinal way side effect of endo-medicine; The crude drug source that the present invention uses is wide, cheap, economical and practical.The present invention still has good effect to the prevention of urticaria, can improve patient's quality of life.
The specific embodiment
For ease of understanding the present invention, it is as follows that the present invention enumerates embodiment.Those skilled in the art should understand, described embodiment only, for helping to understand the present invention, should not be considered as concrete restriction of the present invention.
Embodiment 1
Treat an external application Chinese medicine powder for allergic skin diseases, fill a prescription as follows:
Herba Schizonepetae 20, Radix Saposhnikoviae 25, Fructus Cnidii 20, Radix Sophorae Flavescentis 15, Herba Xanthii worm 40,30 parts, the Radix Rehmanniae, 115 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of the Radix Paeoniae Albas, 15 parts of the Radixs Polygoni Multiflori, 10 parts, Herba Ephedrae, 10 parts, Herba Spirodelae, 5 parts of Rhizoma Smilacis Glabraes, 2 parts of Periostracum Cicadaes, 0.5 part of Scolopendra.
During preparation, said components drying and crushing is crossed to 100 mesh sieves, during use, with clear water wiping affected part, after drying, powder of the present invention is applied in to affected part, sooner or later respectively smear once.
The tcm diagnosis standard that the Western medicine diagnose standard of working out according to < < clinical dermatology > > and the Chinese medicine industry standard TCM Dermatology disease Standardization of diagnosis and curative effect > > of the < < People's Republic of China (PRC) work out, those selected all meets above-mentioned Western medicine diagnose standard or tcm diagnosis standard to choose 100 examples, the powder of 100 routine patient's external the present embodiment (one day twice) is after 30 days, total effective rate is 81%.
Embodiment 2
Formula is: Herba Schizonepetae 30, Radix Saposhnikoviae 30, Fructus Cnidii 25, Radix Sophorae Flavescentis 18, Herba Xanthii worm 50,40 parts, the Radix Rehmanniae, 20 parts of Radix Angelicae Sinensis, 15 parts of Radix Paeoniae Rubra, 15 parts of the Radix Paeoniae Albas, 20 parts of the Radixs Polygoni Multiflori, 15 parts, Herba Ephedrae, 15 parts, Herba Spirodelae, 7 parts of Rhizoma Smilacis Glabraes, 3 parts of Periostracum Cicadaes, 1 part of Scolopendra.
Embodiment 3
Formula is: Herba Schizonepetae 10, Radix Saposhnikoviae 20, Fructus Cnidii 15, Radix Sophorae Flavescentis 12, Herba Xanthii worm 30,20 parts, the Radix Rehmanniae, 10 parts of Radix Angelicae Sinensis, 5 parts of Radix Paeoniae Rubra, 5 parts of the Radix Paeoniae Albas, 10 parts of the Radixs Polygoni Multiflori, 5 parts, Herba Ephedrae, 5 parts, Herba Spirodelae, Rhizoma Smilacis Glabrae 3,1 part of Periostracum Cicadae, 0.3 part of Scolopendra.
Model case: Mr. Cheng, male, 52 years old, repeatedly whole body pruritus companion's red grouper pimple year, arm and shank are serious, in the past transference cure after the oral antiallergic agent of infusing, this outbreak symptom is even more serious than in the past, then goes to a doctor, and gives the powder after 15 days of smearing embodiment 1 for one day twice, arm and the infiltration of shank illing skin reduce, and pruritus symptom is obviously improved, and welt quantity reduces, external after 30 days without pruritus symptom, welt disappears, and clinical sign disappears, and does not reaccess.
Applicant's statement, person of ordinary skill in the field is on the basis of above-described embodiment, by the concrete content point value of above-described embodiment component, combined with the technical scheme of summary of the invention part, thereby the new numerical range producing, also be one of record scope of the present invention, the application, for making description simple and clear, is no longer enumerated these numerical rangies.

Claims (3)

1. an external application Chinese medicine powder for the treatment of allergic skin diseases, is characterized in that, described Chinese medicine powder is crossed 100 mesh sieves by the component drying and crushing of following weight portion and is prepared from:
Herba Schizonepetae 10~30, Radix Saposhnikoviae 20~30, Fructus Cnidii 15~25, Radix Sophorae Flavescentis 12~18, Herba Xanthii worm 30~50,20~40 parts, the Radix Rehmanniae, 10~20 parts of Radix Angelicae Sinensis, 5~15 parts of Radix Paeoniae Rubra, 5~15 parts of the Radix Paeoniae Albas, 10~20 parts of the Radixs Polygoni Multiflori, 5~15 parts, Herba Ephedrae, 5~15 parts, Herba Spirodelae, 3~7 parts of Rhizoma Smilacis Glabraes, 1~3 part of Periostracum Cicadae, 0.3~1 part of Scolopendra.
2. according to a kind of external application Chinese medicine powder for the treatment of allergic skin diseases claimed in claim 1, it is characterized in that, described Chinese medicine powder is crossed 100 mesh sieves by the component drying and crushing of following weight portion and is prepared from:
Herba Schizonepetae 10~20, Radix Saposhnikoviae 20~30, Fructus Cnidii 15~25, Radix Sophorae Flavescentis 12~15, Herba Xanthii worm 30~40,20~30 parts, the Radix Rehmanniae, 10~20 parts of Radix Angelicae Sinensis, 5~10 parts of Radix Paeoniae Rubra, 5~10 parts of the Radix Paeoniae Albas, 10~15 parts of the Radixs Polygoni Multiflori, 5~10 parts, Herba Ephedrae, 5~15 parts, Herba Spirodelae, 3~7 parts of Rhizoma Smilacis Glabraes, 1~3 part of Periostracum Cicadae, 0.3~1 part of Scolopendra.
3. according to a kind of external application Chinese medicine powder for the treatment of allergic skin diseases claimed in claim 1, it is characterized in that, described Chinese medicine powder is crossed 100 mesh sieves by the component drying and crushing of following weight portion and is prepared from:
Herba Schizonepetae 20, Radix Saposhnikoviae 25, Fructus Cnidii 20, Radix Sophorae Flavescentis 15, Herba Xanthii worm 40,30 parts, the Radix Rehmanniae, 115 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of the Radix Paeoniae Albas, 15 parts of the Radixs Polygoni Multiflori, 10 parts, Herba Ephedrae, 10 parts, Herba Spirodelae, 5 parts of Rhizoma Smilacis Glabraes, 2 parts of Periostracum Cicadaes, 0.5 part of Scolopendra.
CN201310513622.XA 2013-10-25 2013-10-25 Externally-used traditional Chinese medicinal pulvis for treating allergic skin diseases Pending CN103599329A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310513622.XA CN103599329A (en) 2013-10-25 2013-10-25 Externally-used traditional Chinese medicinal pulvis for treating allergic skin diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310513622.XA CN103599329A (en) 2013-10-25 2013-10-25 Externally-used traditional Chinese medicinal pulvis for treating allergic skin diseases

Publications (1)

Publication Number Publication Date
CN103599329A true CN103599329A (en) 2014-02-26

Family

ID=50117635

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310513622.XA Pending CN103599329A (en) 2013-10-25 2013-10-25 Externally-used traditional Chinese medicinal pulvis for treating allergic skin diseases

Country Status (1)

Country Link
CN (1) CN103599329A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106727897A (en) * 2016-12-29 2017-05-31 陈国忠 A kind of Chinese medicine preparation for treating allergic conditions and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1343506A (en) * 2000-09-15 2002-04-10 海国灿 Chinese patent medicine for treating allergic dermatopathy
CN1943745A (en) * 2006-10-23 2007-04-11 王信锁 A Chinese traditional medicinal preparation for treatment of urticaria
CN102370914A (en) * 2011-10-21 2012-03-14 马良玉 Oral Chinese patent medicine pill for treating urticaria

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1343506A (en) * 2000-09-15 2002-04-10 海国灿 Chinese patent medicine for treating allergic dermatopathy
CN1943745A (en) * 2006-10-23 2007-04-11 王信锁 A Chinese traditional medicinal preparation for treatment of urticaria
CN102370914A (en) * 2011-10-21 2012-03-14 马良玉 Oral Chinese patent medicine pill for treating urticaria

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
姚晓虹: "中医分型治疗荨麻疹150例", 《陕西中医函授》, no. 03, 31 December 1991 (1991-12-31) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106727897A (en) * 2016-12-29 2017-05-31 陈国忠 A kind of Chinese medicine preparation for treating allergic conditions and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101254255B (en) Traditional Chinese medicine preparation for curing cold
CN103223118B (en) Traditional Chinese medicine composition for treating facial paralysis
CN103720996A (en) Traditional Chinese medicinal composition for treating dysmenorrhea
CN103585401A (en) Traditional Chinese medicine composition for treating bird flu and preparation method therefor.
CN104043087A (en) Traditional Chinese medicine composition for treating Raynaud syndrome
CN103211990B (en) Chinese medicinal composition for treating oral ulcer
CN103550376B (en) A kind of Chinese medicine composition for the treatment of rubella
CN101028372B (en) Chinese medicinal decoction for treating hives
CN102988804A (en) Chinese medicine composition for treating wind-heat type common cold
CN103550642B (en) A kind of Chinese medicine composition for the treatment of wind-warm lung-heat disease caused by wind-heat invading the lung
CN103599329A (en) Externally-used traditional Chinese medicinal pulvis for treating allergic skin diseases
CN105381291A (en) Traditional Chinese medicine composition for preventing and treating pneumonia, preparation method and applications thereof
CN104225376A (en) Traditional Chinese medicinal composition for treating pernicious vomiting due to liver-stomach disharmony and application thereof
CN102973711A (en) Traditional Chinese medicine decoction for treating urticaria
CN102716244A (en) Vietnamese sophora root Chinese medicine preparation for treating headache and preparation method of same
CN102406879A (en) Chinese medicine composition for treating rhinitis
CN105663874A (en) Traditional Chinese medicine composition for treating chronic rhinitis
CN105816613A (en) Traditional Chinese medicine composition for treating headache caused by liver-yang hyperactivity
CN103566256A (en) Traditional Chinese medicine composition for treating urticaria
CN103989842A (en) Traditional Chinese medicine composition for treating rubella
CN102940792A (en) Traditional Chinese medicine composition for treating wind-warm syndrome
CN103007076A (en) Chinese medicinal composition for treating acute bronchitis
CN107050205A (en) One kind treats roseolous Chinese medicine composition
CN105079643A (en) Traditional Chinese medicine composition for treating pertussis
CN105770434A (en) Traditional Chinese medicine composition for treating dental ulcer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140226